Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome

Status:
Completed

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the safety and efficacy of TLK199 in patients with myelodysplastic syndrome (MDS).

Phase 1/Phase 2

Telik